Flow diverter for the treatment of large (> 10 mm) vertebral artery dissecting aneurysms

Surpass Evolve Flow Diverter for the Treatment of Intracranial Aneurysm: A Systematic Review

“…Subsequently, 904 documents were excluded based on title and abstract screening against the inclusion/exclusion criteria. A further 38 were excluded at the full-text screening for not meeting the inclusion criteria, leaving five studies for quality assessment [ 15 , 16 , 21 , 22 , 23 ] (see Figure 1 for PRISMA flow chart).…”

“…However, due to the very limited number of available studies, none were excluded at the quality assessment stage. A total of three case series scored 5/5 stars [ 15 , 22 , 23 ]. The remaining case series [ 16 ] scored 4/5 stars.…”

“…A total of three studies used the retrospective case series design [ 15 , 22 , 23 ], one used the prospective case series [ 16 ], and one used the retrospective cohort design [ 21 ]. Two studies were conducted in the Republic of Korea [ 21 , 22 ], two in Europe [ 15 , 23 ], and one in Canada [ 16 ]. The mean age for the participants ranged between 54.6 and 58 years.…”

“…All studies aimed to determine the safety and efficacy of using the new SE-FDs with two of the studies [ 21 , 22 ] comparing it with other FDs. The focus of all studies was on the clinical outcome of using SE-FDs, which includes aneurysm occlusion and clinical safety.…”

“…All studies employed dual antiplatelet therapy (DAPT) using aspirin and clopidogrel for 3–14 days or bolus dose 1–2 days before surgery. In four of the included studies [ 15 , 21 , 22 , 23 ] the platelet function was assessed either using VerifyNow or Multiplate Analyzer. Based on the platelet function assessment, poor responders to clopidogrel were switched to ticlopidine or prasugrel.…”